title: Oral potassium iodide for the treatment of sporotrichosis.
abstract: Potassium Iodide is the antimycotic of choice for the treatment of cutaneous sporotrichosis, because of its efficacy, safety and low cost. We carried out a review of published studies on the benefits and adverse reactions of using SSKI (Saturated Solution Potassium Iodide) as treatment for sporotrichosis, but could not identify any well-designed clinical trails. There is an urgent need to conduct randomized double-blind placebo-controlled trials and critically assess usefulness of SSKI by using a standardize monitoring or an effective self-report system.
authors.affiliation: Department of Dermatology, West China Hospital, Sichuan University, Guoxuexiang, PR China. xuesiliang@gmail.com
authors.forename: Si-Liang
authors.initials: SL
authors.lastname: Xue
authors.forename: Li
authors.initials: L
authors.lastname: Li
mesh_terms: D000284:Administration, Oral; D006801:Humans; D011193:Potassium Iodide / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013174:Sporotrichosis / Q000188:drug therapy*
chemical_list: D011193:Potassium Iodide